The study uses epidemiological modeling and economic analysis to estimate the potential public health impact of the introduction of an effective microbicide in lower-income countries. The measurement of this public health impact is done in two ways: first, in terms of the number of HIV infections that could be potentially averted over three years by widespread microbicide introduction and use; and second, by estimating the global economic benefits of preventing these HIV infections. The focus of the analysis is on quantifying the public health benefit of the widespread distribution and use of microbicides in seventy-three lower-income countries.
A report by the Public Health Working Group of the Microbicide Initiative. New York: Rockefeller Foundation